Literature DB >> 16936250

Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!

Hyoung-gon Lee1, Xiongwei Zhu, Akihiko Nunomura, George Perry, Mark A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16936250      PMCID： PMC1698831          DOI： 10.2353/ajpath.2006.060633

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  16 in total

1.  Amyloid-beta junkies.

Authors:  G Perry; A Nunomura; A K Raina; M A Smith
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Predicting the failure of amyloid-beta vaccine.

Authors:  Mark A Smith; Craig S Atwood; James A Joseph; George Perry
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

Review 3.  Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease.

Authors:  Hyoung-Gon Lee; Gemma Casadesus; Xiongwei Zhu; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 4.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

5.  Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.

Authors:  R Lyle Patton; Walter M Kalback; Chera L Esh; Tyler A Kokjohn; Gregory D Van Vickle; Dean C Luehrs; Yu-Min Kuo; John Lopez; Daniel Brune; Isidro Ferrer; Eliezer Masliah; Amanda J Newel; Thomas G Beach; Eduardo M Castaño; Alex E Roher
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Set back to Alzheimer vaccine studies.

Authors:  Karen Birmingham; Simon Frantz
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

Review 7.  The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.

Authors:  Catherine A Rottkamp; Craig S Atwood; James A Joseph; Akihiko Nunomura; George Perry; Mark A Smith
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

8.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

Authors:  Christoph Hock; Uwe Konietzko; Johannes R Streffer; Jay Tracy; Andri Signorell; Britta Müller-Tillmanns; Ulrike Lemke; Katharina Henke; Eva Moritz; Esmeralda Garcia; M Axel Wollmer; Daniel Umbricht; Dominique J F de Quervain; Marc Hofmann; Alessia Maddalena; Andreas Papassotiropoulos; Roger M Nitsch
Journal:  Neuron       Date:  2003-05-22       Impact factor: 17.173
View more
  5 in total

Review 1.  Alzheimer disease pathology as a host response.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

Review 2.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

3.  Frontiers in the pathogenesis of Alzheimer's disease.

Authors:  Kumar Sambamurti; K S Jagannatha Rao; Miguel A Pappolla
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

4.  Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.

Authors:  Jonathan H Williams; Gordon K Wilcock; Jeffrey Seeburger; Aimee Dallob; Omar Laterza; William Potter; A David Smith
Journal:  Alzheimers Res Ther       Date:  2011-02-17       Impact factor: 6.982

Review 5.  Mechanism-based treatments for Alzheimer's disease.

Authors:  Peter Davies; Jeremy Koppel
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.